Does the media refer more to MMSI or CNMD?

In the previous week, Merit Medical Systems had 19 more articles in the media than CONMED. MarketBeat recorded 24 mentions for Merit Medical Systems and 5 mentions for CONMED. Merit Medical Systems' average media sentiment score of 1.30 beat CONMED's score of 0.95 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 11 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, TFX or CNMD?

CONMED has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $1.99B 2.97 -$905.64M -$23.29 N/A CONMED $1.37B 1.09 $47.06M $1.85 26.98

Is TFX or CNMD more profitable?

CONMED has a net margin of 4.12% compared to Teleflex's net margin of -39.67%. CONMED's return on equity of 14.31% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -39.67% 11.93% 5.44% CONMED 4.12% 14.31% 6.33%

Does the media prefer TFX or CNMD?

In the previous week, Teleflex had 6 more articles in the media than CONMED. MarketBeat recorded 11 mentions for Teleflex and 5 mentions for CONMED. CONMED's average media sentiment score of 0.95 beat Teleflex's score of 0.87 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CNMD or MMED?

In the previous week, MiniMed Group had 5 more articles in the media than CONMED. MarketBeat recorded 10 mentions for MiniMed Group and 5 mentions for CONMED. MiniMed Group's average media sentiment score of 1.07 beat CONMED's score of 0.95 indicating that MiniMed Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CNMD or HAE more profitable?

Haemonetics has a net margin of 7.12% compared to CONMED's net margin of 4.12%. Haemonetics' return on equity of 27.55% beat CONMED's return on equity. Company Net Margins Return on Equity Return on Assets CONMED 4.12% 14.31% 6.33% Haemonetics 7.12% 27.55% 9.65%

Does the media favor CNMD or HAE?

In the previous week, Haemonetics had 15 more articles in the media than CONMED. MarketBeat recorded 20 mentions for Haemonetics and 5 mentions for CONMED. CONMED's average media sentiment score of 0.95 beat Haemonetics' score of 0.68 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, LIVN or CNMD?

CONMED has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LivaNova $1.39B 3.19 -$242.47M $3.38 23.76 CONMED $1.37B 1.09 $47.06M $1.85 26.98

Is LIVN or CNMD more profitable?

LivaNova has a net margin of 12.82% compared to CONMED's net margin of 4.12%. LivaNova's return on equity of 16.35% beat CONMED's return on equity. Company Net Margins Return on Equity Return on Assets LivaNova 12.82% 16.35% 7.76% CONMED 4.12% 14.31% 6.33%

Does the media refer more to LIVN or CNMD?

In the previous week, CONMED had 2 more articles in the media than LivaNova. MarketBeat recorded 5 mentions for CONMED and 3 mentions for LivaNova. LivaNova's average media sentiment score of 1.08 beat CONMED's score of 0.95 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

CONMED (CNMD) Competitors

$49.92 -0.40 (-0.79%)

As of 08/28/2026 03:58 PM Eastern

Compare

CNMD vs. MMSI, TFX, MMED, HAE, and LIVN

Should you buy CONMED stock or one of its competitors? CONMED's main competitors and comparable companies include Merit Medical Systems (MMSI), Teleflex (TFX), MiniMed Group (MMED), Haemonetics (HAE), and LivaNova (LIVN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does CONMED compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Merit Medical Systems has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.56	$128.49M	$2.42	37.39
CONMED	$1.37B	1.09	$47.06M	$1.85	26.98

In the previous week, Merit Medical Systems had 19 more articles in the media than CONMED. MarketBeat recorded 24 mentions for Merit Medical Systems and 5 mentions for CONMED. Merit Medical Systems' average media sentiment score of 1.30 beat CONMED's score of 0.95 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	11 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.7% of Merit Medical Systems shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by company insiders. Comparatively, 0.3% of CONMED shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Merit Medical Systems presently has a consensus target price of $100.00, indicating a potential upside of 10.51%. CONMED has a consensus target price of $41.40, indicating a potential downside of 17.07%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Merit Medical Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

Merit Medical Systems has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market. Comparatively, CONMED has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.22%	13.75%	8.10%
CONMED	4.12%	14.31%	6.33%

Summary

Merit Medical Systems beats CONMED on 15 of the 17 factors compared between the two stocks.

How does CONMED compare to Teleflex?

Teleflex (NYSE:TFX) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

95.6% of Teleflex shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 0.3% of CONMED shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Teleflex has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, CONMED has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

CONMED has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	2.97	-$905.64M	-$23.29	N/A
CONMED	$1.37B	1.09	$47.06M	$1.85	26.98

Teleflex presently has a consensus price target of $152.90, indicating a potential upside of 9.36%. CONMED has a consensus price target of $41.40, indicating a potential downside of 17.07%. Given Teleflex's stronger consensus rating and higher possible upside, research analysts clearly believe Teleflex is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

CONMED has a net margin of 4.12% compared to Teleflex's net margin of -39.67%. CONMED's return on equity of 14.31% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-39.67%	11.93%	5.44%
CONMED	4.12%	14.31%	6.33%

In the previous week, Teleflex had 6 more articles in the media than CONMED. MarketBeat recorded 11 mentions for Teleflex and 5 mentions for CONMED. CONMED's average media sentiment score of 0.95 beat Teleflex's score of 0.87 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	8 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Teleflex beats CONMED on 9 of the 17 factors compared between the two stocks.

How does CONMED compare to MiniMed Group?

CONMED (NYSE:CNMD) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

In the previous week, MiniMed Group had 5 more articles in the media than CONMED. MarketBeat recorded 10 mentions for MiniMed Group and 5 mentions for CONMED. MiniMed Group's average media sentiment score of 1.07 beat CONMED's score of 0.95 indicating that MiniMed Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CONMED presently has a consensus target price of $41.40, suggesting a potential downside of 17.07%. MiniMed Group has a consensus target price of $21.62, suggesting a potential upside of 7.54%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts plainly believe MiniMed Group is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

CONMED has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.09	$47.06M	$1.85	26.98
MiniMed Group	$3.10B	1.82	-$333M	-$0.68	N/A

CONMED has a net margin of 4.12% compared to MiniMed Group's net margin of 0.00%. CONMED's return on equity of 14.31% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
MiniMed Group	N/A	N/A	N/A

Summary

MiniMed Group beats CONMED on 7 of the 13 factors compared between the two stocks.

How does CONMED compare to Haemonetics?

CONMED (NYSE:CNMD) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

CONMED has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

99.7% of Haemonetics shares are owned by institutional investors. 0.3% of CONMED shares are owned by company insiders. Comparatively, 2.1% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Haemonetics has a net margin of 7.12% compared to CONMED's net margin of 4.12%. Haemonetics' return on equity of 27.55% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Haemonetics	7.12%	27.55%	9.65%

In the previous week, Haemonetics had 15 more articles in the media than CONMED. MarketBeat recorded 20 mentions for Haemonetics and 5 mentions for CONMED. CONMED's average media sentiment score of 0.95 beat Haemonetics' score of 0.68 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CONMED currently has a consensus price target of $41.40, suggesting a potential downside of 17.07%. Haemonetics has a consensus price target of $97.56, suggesting a potential downside of 6.04%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts clearly believe Haemonetics is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Haemonetics has lower revenue, but higher earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.09	$47.06M	$1.85	26.98
Haemonetics	$1.33B	3.54	$97.31M	$2.04	50.90

Summary

Haemonetics beats CONMED on 14 of the 17 factors compared between the two stocks.

How does CONMED compare to LivaNova?

LivaNova (NASDAQ:LIVN) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

LivaNova has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, CONMED has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

LivaNova has a net margin of 12.82% compared to CONMED's net margin of 4.12%. LivaNova's return on equity of 16.35% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	12.82%	16.35%	7.76%
CONMED	4.12%	14.31%	6.33%

In the previous week, CONMED had 2 more articles in the media than LivaNova. MarketBeat recorded 5 mentions for CONMED and 3 mentions for LivaNova. LivaNova's average media sentiment score of 1.08 beat CONMED's score of 0.95 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

CONMED has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.19	-$242.47M	$3.38	23.76
CONMED	$1.37B	1.09	$47.06M	$1.85	26.98

97.6% of LivaNova shares are owned by institutional investors. 0.4% of LivaNova shares are owned by company insiders. Comparatively, 0.3% of CONMED shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

LivaNova presently has a consensus price target of $83.50, suggesting a potential upside of 3.96%. CONMED has a consensus price target of $41.40, suggesting a potential downside of 17.07%. Given LivaNova's stronger consensus rating and higher possible upside, equities analysts plainly believe LivaNova is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

Summary

LivaNova beats CONMED on 12 of the 16 factors compared between the two stocks.

Get CONMED News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNMD vs. The Competition

Export

Metric	CONMED	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.50B	$5.88B	$7.21B	$24.18B
Dividend Yield	N/A	1.75%	2.54%	3.72%
P/E Ratio	26.98	25.92	273.16	30.01
Price / Sales	1.09	69.46	629.76	20.38
Price / Cash	6.94	33.69	28.74	19.75
Price / Book	1.50	6.18	11.08	4.84
Net Income	$47.06M	$149.94M	$3.48B	$1.07B
7 Day Performance	-2.63%	-0.24%	0.13%	-0.32%
1 Month Performance	6.12%	6.18%	7.08%	1.84%
1 Year Performance	-8.14%	6.30%	24.67%	13.37%

CONMED Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNMD CONMED	1.5869 of 5 stars	$49.92 -0.8%	$41.40 -17.1%	-8.1%	$1.50B	$1.37B	26.98	3,900
MMSI Merit Medical Systems	4.0089 of 5 stars	$90.28 -0.6%	$100.00 +10.8%	-0.1%	$5.42B	$1.52B	37.31	7,500	Positive News Analyst Upgrade Analyst Revision
TFX Teleflex	4.1096 of 5 stars	$138.31 -0.4%	$152.90 +10.6%	+10.5%	$5.88B	$1.99B	N/A	15,500	Positive News Analyst Forecast Short Interest Increase
MMED MiniMed Group	1.7688 of 5 stars	$19.94 -2.5%	$21.62 +8.4%	N/A	$5.74B	$3.10B	N/A	2,800	News Coverage Lockup Expiration
HAE Haemonetics	2.6602 of 5 stars	$108.34 -0.4%	$97.56 -10.0%	+90.1%	$4.95B	$1.35B	53.11	3,009	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNMD) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONMED (CNMD) Competitors

CNMD vs. MMSI, TFX, MMED, HAE, and LIVN

How does CONMED compare to Merit Medical Systems?

Summary

How does CONMED compare to Teleflex?

Summary

How does CONMED compare to MiniMed Group?

Summary

How does CONMED compare to Haemonetics?

Summary

How does CONMED compare to LivaNova?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CONMED (CNMD) Competitors

CNMD vs. MMSI, TFX, MMED, HAE, and LIVN

How does CONMED compare to Merit Medical Systems?

Which has stronger valuation & earnings, MMSI or CNMD?

Does the media refer more to MMSI or CNMD?

Do institutionals & insiders believe in MMSI or CNMD?

Do analysts recommend MMSI or CNMD?

Which has more risk and volatility, MMSI or CNMD?

Is MMSI or CNMD more profitable?

Summary

How does CONMED compare to Teleflex?

Do insiders & institutionals believe in TFX or CNMD?

Which has more volatility and risk, TFX or CNMD?

Which has better earnings and valuation, TFX or CNMD?

Do analysts recommend TFX or CNMD?

Is TFX or CNMD more profitable?

Does the media prefer TFX or CNMD?

Summary

How does CONMED compare to MiniMed Group?

Does the media refer more to CNMD or MMED?

Do analysts rate CNMD or MMED?

Which has stronger valuation & earnings, CNMD or MMED?

Is CNMD or MMED more profitable?

Summary

How does CONMED compare to Haemonetics?

Which has more risk and volatility, CNMD or HAE?

Do institutionals and insiders hold more shares of CNMD or HAE?

Is CNMD or HAE more profitable?

Does the media favor CNMD or HAE?

Do analysts rate CNMD or HAE?

Which has higher earnings and valuation, CNMD or HAE?

Summary

How does CONMED compare to LivaNova?

Which has more volatility & risk, LIVN or CNMD?

Is LIVN or CNMD more profitable?

Does the media refer more to LIVN or CNMD?

Which has stronger earnings & valuation, LIVN or CNMD?

Do insiders & institutionals have more ownership in LIVN or CNMD?

Do analysts prefer LIVN or CNMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools